Vir Biotechnology (VIR) Accumulated Depreciation (2018 - 2023)

Vir Biotechnology's Accumulated Depreciation history runs 6 years deep, the most recent figure standing at $26.2 million for Q1 2023.

• In Q1 2023, Accumulated Depreciation rose 65.06% year-over-year to $26.2 million; the TTM figure through Mar 2023 stood at $26.2 million (up 65.06% YoY), while the FY2022 annual figure was $20.7 million, up 43.13% from the prior year.
• Accumulated Depreciation came in at $26.2 million for Q1 2023 at Vir Biotechnology, up from $20.7 million in the prior quarter.
• In the past five years, Accumulated Depreciation ranged from a high of $26.2 million in Q1 2023 to a low of $4.2 million in Q3 2019.
• A 5-year average of $12.5 million and a median of $11.8 million in 2021 frame the typical range for Accumulated Depreciation.
• Across the five-year window, Accumulated Depreciation surged 181.59% in 2019 and surged 43.13% in 2022, its largest moves.
• Vir Biotechnology's Accumulated Depreciation stood at $4.8 million in 2019, then jumped by 91.06% to $9.2 million in 2020, then soared by 56.98% to $14.5 million in 2021, then jumped by 43.13% to $20.7 million in 2022, then increased by 26.54% to $26.2 million in 2023.
• According to Business Quant data, Accumulated Depreciation over the past three periods registered $26.2 million, $20.7 million, and $18.9 million for Q1 2023, Q4 2022, and Q3 2022 respectively.

Peer Comparison